Artiva Biotherapeutics (ARTV) Insider Trading & Ownership $10.58 -0.02 (-0.19%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Artiva Biotherapeutics (NASDAQ:ARTV) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$30.00 MNumber OfInsiders Selling(Last 12 Months)0 Get ARTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARTV Insider Buying and Selling by Quarter Ad Brownstone ResearchMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. Artiva Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/22/2024Global Strategic Fund I VenbioMajor ShareholderBuy416,666$12.00$4,999,992.00 7/22/2024Yong-Jun HuhDirectorBuy2,083,332$12.00$24,999,984.00 (Data available from 1/1/2013 forward) ARTV Insider Trading Activity - Frequently Asked Questions Who is on Artiva Biotherapeutics's Insider Roster? The list of insiders at Artiva Biotherapeutics includes Global Strategic Fund I Venbio, and Yong-Jun Huh. Learn more on insiders at ARTV. Which Artiva Biotherapeutics insiders have been buying company stock? The following insiders have purchased ARTV shares in the last 24 months: Global Strategic Fund I Venbio ($4,999,992.00), and Yong-Jun Huh ($24,999,984.00). How much insider buying is happening at Artiva Biotherapeutics? Insiders have purchased a total of 2,499,998 ARTV shares in the last 24 months for a total of $29,999,976.00 bought. Artiva Biotherapeutics Key ExecutivesDr. Fred Aslan M.D. (Age 49)President, CEO & Director Compensation: $917.3kDr. Peter Flynn Ph.D. (Age 50)Co-Founder & Strategic Advisor Compensation: $499.37kMs. Jennifer Kinsbruner Bush Esq. (Age 49)J.D., Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer Compensation: $630.31kMr. Christopher P. Horan (Age 57)Chief Technical Operations Officer Compensation: $612.23kMs. Neha Krishnamohan (Age 37)CFO & Executive VP of Corporate Development Dr. Thorsten Graef M.D. (Age 48)Ph.D., Chief Medical Officer Dr. Heather Raymon Ph.D. (Age 60)Senior Vice President of Research & Early Development Mr. Eugene HelselSenior Vice President of Regulatory AffairsDr. K. C Lim Pharm.D.Senior Vice President of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies VIR Insider Trades AVXL Insider Trades PSTX Insider Trades ADPT Insider Trades REPL Insider Trades LENZ Insider Trades RLAY Insider Trades CGEM Insider Trades TECX Insider Trades HUMA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? This page (NASDAQ:ARTV) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARTV Stock Alerts